Piper Sandler Advises Bain and Cinven on their acquisition of Lonza Specialty Ingredients
Piper Sandler acted as lead financial advisor for Bain Capital Private Equity and Cinven in their acquisition of Lonza Specialty Ingredients (LSI) for CHF 4.2 billion (USD 4.7 billion). This deal is expected to close in 2021, pending regulatory approval. LSI provides specialty chemicals for microbial control and serves around 5,300 customers globally, with a workforce of approximately 2,800 employees and multiple R&D and manufacturing sites. Piper Sandler emphasized its strong presence in European investment banking through this significant cross-border transaction.
- Acquisition valued at CHF 4.2 billion (USD 4.7 billion) highlights strong market position.
- LSI's products are essential in various industries, including personal care and industrial usage.
- Piper Sandler's involvement showcases expertise in high-value cross-border transactions.
- None.
Piper Sandler & Co. chemicals & materials investment banking group (The Valence Group) served as lead financial advisor to Bain Capital Private Equity and Cinven on their joint acquisition of Lonza Specialty Ingredients (LSI), a division of Lonza AG. The transaction, valued at CHF 4.2 billion (USD 4.7 billion), is expected to close in 2021, subject to customary closing conditions including regulatory clearances.
LSI is a world-leading provider of specialty chemicals for microbial control solutions, used to eliminate or control harmful and unwanted micro-organisms. LSI’s products are critical ingredients in disinfectants, preservatives, sanitizers, personal care products, as well as coatings and other industrial uses. Headquartered in Basel, Switzerland, LSI has approximately 2,800 employees, 11 R&D centers and 17 manufacturing sites across the world. The business serves circa 5,300 customers across a wide range of end-markets.
“Piper Sandler is extremely pleased to have played a significant supporting role in advising two long-term private equity clients in such a landmark transaction,” said Telly Zachariades, co-head of chemicals & materials investment banking at Piper Sandler (New York).
Anton Ticktin, managing director, Piper Sandler (London), further commented, “Our team has helped to deliver yet another multi-billion dollar, cross-border transaction, one of the largest LBOs in the chemical industry.” Ian George, managing director, Piper Sandler (London), added, “We look forward to helping Bain and Cinven write the next chapter of the LSI story.”
Peter Hall, head of European investment banking at Piper Sandler stated, “This transaction reflects the strong position we have in targeted sectors of the European investment banking market”.
ABOUT PIPER SANDLER
Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in Europe through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; and in Hong Kong through Piper Sandler Hong Kong Limited, authorized and regulated by the Securities and Futures Commission. Private equity strategies and fixed income advisory services are offered through separately registered advisory affiliates.
Follow Piper Sandler: LinkedIn | Facebook | Twitter
©2021. Since 1895. Piper Sandler Companies. 800 Nicollet Mall, Minneapolis, Minnesota 55402-7036
View source version on businesswire.com: https://www.businesswire.com/news/home/20210209006085/en/
FAQ
What is the value of the Lonza Specialty Ingredients acquisition?
Who advised Bain Capital and Cinven on the Lonza Specialty Ingredients acquisition?
What industry does Lonza Specialty Ingredients operate in?
When is the expected closing date for the acquisition?
